NYSE$MOH

Molina Healthcare Inc · Q4 2022 earnings

Q4 2022 earnings · · Investor relations

Briefing

Molina Healthcare reported a strong Q4 2022 with GAAP earnings per diluted share of $0.96 and adjusted earnings per diluted share of $4.10.

Molina Healthcare reported a strong fourth quarter and year-end 2022, with significant increases in premium revenue and adjusted earnings per share. The company's growth strategy and disciplined cost management contributed to a solid financial profile heading into 2023. Full year 2023 earnings guidance was issued with expected premium revenue of $32 billion and adjusted earnings of at least $19.75 per diluted share.

  • Premium revenue was $7.917 billion for the fourth quarter of 2022.
  • GAAP earnings per diluted share were $0.96 for the fourth quarter of 2022.
  • Adjusted earnings per diluted share were $4.10 for the fourth quarter of 2022.
  • The company served approximately 5.3 million members as of December 31, 2022.

Headline financials

Total Revenue

$8.22B

Previous: $7.41B+11.0%
EPS (adj)

$4.10

Previous: $2.88+42.4%
Total Membership

5.3M

Previous: 5.2M+1.1%
Medicaid Membership

4.8M

Previous: 4.3M+9.8%
Medicare Membership

156.0K

Previous: 142.0K+9.9%
Marketplace Membership

348.0K

Previous: 728.0K-52.2%
Capital Expenditures

$10M

Previous: $21M-52.4%
Free Cash Flow

-$222M

Previous: $576M-138.5%
Net Income

$56M

Previous: $103M-45.6%
Operating Income

$105M

Previous: $191M-45.0%
Gross Profit

$1B

Previous: $836M+20.1%
Cash & Equivalents

$4.01B

Previous: $4.44B-9.7%
Total Assets

$12.3B

Previous: $12.2B+0.9%
Stock-Based Comp

$23M

Previous: $23M+0.0%

Revenue & EPS history

Molina · Revenue · Quarterly

$8.22B

Q4 2022+11%vs Q4 2021
Beat estimate in 11 of 15 quarters(73%)
ActualEstimate

Revenue by segment

Molina · $7.92B total across 3 segments · Q4 2022

  • Medicaid
    $6.42B+18.0%
  • Medicare
    $948M+8.6%
  • Marketplace
    $548M-35.7%

Forward guidance

Molina Healthcare provided full year 2023 earnings guidance with expected premium revenue of $32 billion and adjusted earnings of at least $19.75 per diluted share. Guidance reflects continued realization of embedded earnings, underlying organic growth and operational catalysts, and $0.65 per diluted share of one-time non-recurring implementation costs for new Medicaid contract wins.

Tailwinds

  • Continued realization of embedded earnings
  • Underlying organic growth and operational catalysts

Headwinds

  • $0.65 per diluted share of one-time non-recurring implementation costs for new Medicaid contract wins

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2022

Historical avgQ4 2022

+0.2%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+2.9%

Avg return

30 days after

41%

27 / 66 earnings

Positive

+26.3%

Q1 2017

Best reaction

-25.5%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.6%+21.2%+20.3%
Q4 2025-25.5%-30.6%-18.3%
Q3 2025-17.3%-16.5%-27.5%
Q2 2025+4.9%+8.8%+13.3%
Q1 2025-5.5%-3.7%-8.1%
Q4 2024-10.1%-13.9%+3.3%
Q3 2024+14.0%+11.0%+2.4%
Q2 2024+13.0%+16.1%+20.5%
Q1 2024-3.0%-5.3%-8.6%
Q4 2023+6.8%+9.9%+9.9%
Q3 2023-0.7%-1.7%+10.1%
Q2 2023-2.6%-3.5%+1.0%
Q1 2023+6.3%+9.4%-2.2%
Q4 2022-0.5%-1.1%-13.7%
Q3 2022-3.9%-2.0%-10.7%
Q2 2022+2.7%+5.3%+9.7%
Q1 2022-1.9%-4.7%-5.1%
Q4 2021-0.5%-0.0%+1.8%
Q3 2021-0.8%-0.5%-2.4%
Q2 2021-2.0%+5.4%+3.2%
Q1 2021+1.2%+2.2%+0.2%
Q4 2020+5.0%+5.0%+12.9%
Q3 2020-8.2%-2.5%+1.5%
Q2 2020-1.6%-0.5%-2.0%
Q1 2020+5.2%+9.9%+12.8%
Q4 2019+10.5%+13.3%+3.1%
Q3 2019-0.3%-4.4%+11.0%
Q2 2019-4.4%-7.0%-6.5%
Q1 2019+0.9%-0.2%+2.0%
Q4 2018-5.5%-1.1%+3.6%
Q3 2018-0.8%-0.9%+11.1%
Q2 2018+18.7%+23.1%+34.7%
Q1 2018-2.9%-1.2%+3.4%
Q4 2017-3.8%-8.1%-2.8%
Q3 2017+16.1%+13.7%+14.6%
Q2 2017-6.8%-12.4%-4.0%
Q1 2017+26.3%+30.8%+31.3%
Q4 2016-17.2%+1.6%-6.0%
Q3 2016-5.9%-7.0%-9.3%
Q2 2016+10.1%+8.1%+4.2%
Q1 2016-20.6%
Q4 2015-1.5%
Q3 2015-8.6%
Q2 2015+9.6%
Q1 2015+11.6%
Q4 2014+8.8%
Q3 2014+4.6%
Q2 2014-6.5%
Q1 2014+4.5%
Q4 2013-6.4%
Q3 2013-7.5%
Q2 2013-1.4%
Q1 2013+1.6%
Q4 2012+10.0%
Q3 2012+14.3%
Q2 2012-1.7%
Q1 2011-2.5%
Q1 2012+0.2%
Q4 2011-0.2%
Q1 2010-0.2%
Q4 2009-0.2%
Q3 2010+1.2%
Q3 2011+1.2%
Q2 2011-2.7%
Q4 2010-2.7%
Q2 2010-2.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro